- Home
- VRDN vs TAC Comparison
VRDN vs TAC Comparison
Compare VRDN & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRDN | TAC |
|---|---|---|
| Founded | 2006 | 1909 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VRDN | TAC |
|---|---|---|
| Price | $30.11 | $13.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $41.42 | $21.63 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 1.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $70,789,000.00 | ★ $1,783,342,546.00 |
| Revenue This Year | $26,080.80 | N/A |
| Revenue Next Year | $2.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23340.07 | N/A |
| 52 Week Low | $9.90 | $7.82 |
| 52 Week High | $34.29 | $17.88 |
Technical Indicators
Market Signals| Indicator | VRDN | TAC |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 54.87 |
| Support Level | $28.92 | $13.02 |
| Resistance Level | $30.75 | $13.62 |
| Average True Range (ATR) | 1.47 | 0.55 |
| MACD | -0.40 | 0.08 |
| Stochastic Oscillator | 21.67 | 68.15 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.